Anxiety DisordersNCT05637658
The Effect of Aerobic Exercise on Nomophobia and Anxiety
A study testing Exercise in people with Anxiety Disorders, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students. Read more about this study
- Who is it for?
- Ages 18 to 24 yearsHealthy volunteers can take part
- Conditions the study is for
- Anxiety Disorders
- What is being tested?
- Exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 28 Nov 2022to 20 Jan 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 24 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Individuals who scored above 22 points on the Beck anxiety scale and 60 points or higher on the nomophobia scale
Who cannot join
- any condition that may prevent the participant from exercising
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Aerobic Exercise on Nomophobia and Anxiety in Nomophobic University Students
It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students.
Read the detailed description
It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students. There is no study in the literature examining the relationship between aerobic exercise and nomophobia in young people. Since our study will be the first to investigate the subject, we foresee that it is scientifically important and will shed light on future studies. In addition, national or international publications are planned after the study is completed.
- Conditions
- Anxiety Disorders
- Being tested
- Exercise
- Medical subject headings
- Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExerciseOther
aerobic exercise
| Study group | Role | What they receive |
|---|---|---|
| control group | No intervention | No application will be made to the participants in the control group. |
| Exercise group | Experimental | Participants will perform aerobic exercise 3 times a week at an intensity of 60-80% of age-adjusted maximal heart reserve on the treadmill and bicycle ergometer for 4 weeks. Receives: Other: Exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in nomophobia score at four weeks
The Nomophobia scale, a 7-point Likert scale consisting of 20 questions developed by Yildirim \& Correia, was used to evaluate the nomophobia levels of the participants.Those with a total scores less than 20 did not have nomophobia, 21-59 had mild,60-99 had modarate,and 100-140 had extreme nomophobia
Measured: baseline and 4 weeks
Secondary outcomes (1)
Change from baseline in anxiety score at four weeks
The Beck Anxiety Inventory (BAI), created by Aaron T. Beck and other colleagues, is a 21-question multiple-choice self-report inventory that is used for measuring the severity of anxiety in adolescents and adults ages 17 and older.A maximum of 63 points can be obtained from the scale.Less than 21 points indicates mild anxiety, 22-35 points moderate and above 36 points severe anxiety.
Measured: baseline and 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2022
- Study start28 Nov 2022
- Primary completion28 Dec 2022
- Study completion20 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anxiety DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- parallel assignment
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05637658
- Sponsor's protocol ID
- Karataynomofobia
- Status last verified
- Nov 2022
- First submitted
- 24 Nov 2022
- Last updated
- 21 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Aerobic Exercise on Nomophobia and Anxiety in Nomophobic University Students
- ClinicalTrials.gov ID
- NCT05637658
- Acronym / sponsor ID
- Karataynomofobia
- Conditions
- Anxiety Disorders
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 28 Nov 2022 (actual)
- Primary completion
- 28 Dec 2022 (actual)
- Study completion
- 20 Jan 2023 (actual)
- First posted
- 5 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students.
Detailed description
It was aimed to examine the effect of aerobic exercise on nomophobia and anxiety in nomophobic university students. There is no study in the literature examining the relationship between aerobic exercise and nomophobia in young people. Since our study will be the first to investigate the subject, we foresee that it is scientifically important and will shed light on future studies. In addition, national or international publications are planned after the study is completed.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- parallel assignment
| Arm | Type | Receives |
|---|---|---|
| control group | No intervention | –No application will be made to the participants in the control group. |
| Exercise group | Experimental | Other: ExerciseParticipants will perform aerobic exercise 3 times a week at an intensity of 60-80% of age-adjusted maximal heart reserve on the treadmill and bicycle ergometer for 4 weeks. |
Who may qualify
- Ages
- 18 to 24 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Individuals who scored above 22 points on the Beck anxiety scale and 60 points or higher on the nomophobia scale
Key exclusion criteria (1 listed)
- any condition that may prevent the participant from exercising
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exerciseaerobic exercise | Other | Exercise group |
Primary outcome
Change from baseline in nomophobia score at four weeks
Time frame: baseline and 4 weeks
The Nomophobia scale, a 7-point Likert scale consisting of 20 questions developed by Yildirim \& Correia, was used to evaluate the nomophobia levels of the participants.Those with a total scores less than 20 did not have nomophobia, 21-59 had mild,60-99 had modarate,and 100-140 had extreme nomophobia
1 secondary outcome
Change from baseline in anxiety score at four weeks
Time frame: baseline and 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2023.
- Individual participant dataSharing planned: Undecided
Related trials for Anxiety Disorders
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise in people with Anxiety Disorders, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in nomophobia score at four weeks (time frame: baseline and 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.